Profound Medical Sees Q3 Sales $9.800M-$10.000M vs $6.934M Est

Profound Medical (NASDAQ: PROF) reported projected Q3 sales between $9.800 million and $10.000 million, exceeding the analyst estimate of $6.934 million. This indicates a significant growth in sales compared to previous forecasts.